Agile Therapeutics (AGRX)
(Delayed Data from OTC)
$1.47 USD
0.00 (0.00%)
Updated Aug 2, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Agile Therapeutics, Inc. [AGRX]
Reports for Purchase
Showing records 21 - 40 ( 51 total )
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
2Q19 Results and Financing; Optimistic Into October Twirla Adcom and November PDUFA; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Twirla NDA Hopefully on Homestretch; We?d Welcome an AdCom; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Twirla Adhesion Same as It Ever Was (Good); Potential 2Q19 Refiing, AdCom; Then 4Q19 PDUFA; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Quick Twirla Adhesion Trial Should End Tribulations; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
3Q18 Results; Cash Conservation Ahead of Twirla Wear Study; We Still Project Potential 4Q19 Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Twirla FDA Dispute Resolution Yields Rational Compromise and Path Forward; Reiterate Buy and $4 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
No Perfect Patch; Twirla Likely Heading for Dispute Resolution; Lower Target to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
1Q18 Results; Financial Discipline as We Await Twirla FDA Meeting Minutes This Month; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Agile Therapeutics, Inc.
Industry: Medical - Generic Drugs
4Q Results; Twirla Post-CRL Meeting on Tap; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O